Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-03, Stock:PFE, The news for the past five days is as follows:
2020-08-27: NEWS1: Johnson & Johnson stock rises Thursday, outperforms market.NEWS2: Novavax Reportedly Targets December For U.S. Coronavirus Vaccine Application.NEWS3: Coronavirus update: 'Game-changer' Abbott test gets boost from Trump as Moderna shows vaccine progress.NEWS4: Moderna and Pfizer’s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution.NEWS5: Will Moderna or Pfizer Have Better Phase 3 Covid-19 Vaccine Data? Analysts Begin To Make Bets..NEWS6: Pfizer (PFE) Down 3.1% Since Last Earnings Report: Can It Rebound?.NEWS7: Stock market factoring in ‘smooth ride’ to economic recovery: Edward Jones exec.NEWS8: BioNTech, China's Fosun strikes deal to potentially supply 10 mln doses of COVID-19 vaccine.NEWS9: Pfizer Is Out, Honeywell Is In: Should The Dow Jones Shake-Up Change Your Investing Strategy?.NEWS10: Interest Rates Will Remain Low for Years. These High-Quality Stocks Might Offer the Income You Need..NEWS11: Dow Jones: The Real Reason Exxon, Pfizer, and Raytheon Are Being Kicked Out of the Iconic Index.NEWS12: Moderna COVID-19 vaccine appears to work as well in older adults in early study.
2020-08-28: NEWS1: Thousands of Doses of Vaccine Hopefuls Are Ready To Go — If One Works.NEWS2: Johnson & Johnson stock rises Friday, still underperforms market.NEWS3: Investors Are Betting Big on a Covid-19 Vaccine. Is That Safe?.NEWS4: President Trump Promised a Vaccine Before the End of the Year. What You Need to Know..NEWS5: Why Novavax's Coronavirus Vaccine Might Be First to Market.NEWS6: Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally.NEWS7: Better Buy: Eli Lilly vs. Pfizer.NEWS8: Japan, eyeing Olympics, lines up half-billion doses of COVID-19 vaccine.
2020-08-31: NEWS1: Johnson & Johnson stock falls Monday, still outperforms market.NEWS2: GLOBAL MARKETS-Stocks dip but clinch fifth month of gains; dollar soft.NEWS3: Novavax Inks Deal To Sell Coronavirus Vaccine To Canada; Stock Rises.NEWS4: US STOCKS-Nasdaq rallies while S&P 500 heads for biggest August since 1984.NEWS5: GLOBAL MARKETS-Stocks dip but set for fifth month of gains; dollar weak.NEWS6: Pfizer Inc. (PFE): Hedge Funds In Wait-and-See Mode.NEWS7: US STOCKS-Wall St mixed as S&P 500 heads for best August since 1984.NEWS8: Pharmaceutical Companies Are Doing Much More Than Battling COVID-19.NEWS9: Coronavirus update: FDA sparks new debate over 'following Russia, China' in vaccine push.NEWS10: US STOCKS-Wall St mixed as S&P 500 on track for best August in 36 years.NEWS11: GLOBAL MARKETS-Stocks dip but set for fifth month of gains; dollar slips.NEWS12: US STOCKS-S&P 500 stalls at record level, set for best August in 36 years.NEWS13: It’s Crunch Time for Vaccine News. Brace Yourself..
2020-09-01: NEWS1: Johnson & Johnson stock falls Tuesday, underperforms market.NEWS2: Covid Roundup: AstraZeneca U.S. Phase 3 Vaccine Trials Start; Sanofi Drug Fails Test.NEWS3: The Zacks Analyst Blog Highlights: PFE, XOM, CRM, AMGN and AAPL.NEWS4: AstraZeneca Began a Big Covid Vaccine Trial Monday. It Probably Won’t Be the First to Release Data..NEWS5: Global Markets Review: Dow Dumps Exxon and Fed Targets Inflation.NEWS6: 'Fast Money' Traders Advise Viewer On Pfizer.NEWS7: Lessons for Equity Investors From Dow Jones' Big Shake-Up.NEWS8: GLOBAL MARKETS-Asian stocks edge lower after Wall Street dips in month-end trade.
2020-09-02: NEWS1: U.S. CDC tells states to prep for COVID-19 vaccine distribution by Nov.NEWS2: Johnson & Johnson stock rises Wednesday, still underperforms market.NEWS3: Why These 3 Coronavirus Stocks Are Falling This Week.NEWS4: 3 Pharma Stocks That Are COVID-19 Resistant.NEWS5: Is Amgen (AMGN) a Good Choice for Dow Membership?.NEWS6: Pfizer Has Been a Mediocre Stock at Best. Here's Why You Should Consider Buying It Anyway.NEWS7: Sadly, One Letter Perfectly Captures the Recovery.

Answer: Decrease